| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/11/2002 | CN1368093A Nano medicine 'Luxue' and its preparing process |
| 09/11/2002 | CN1368086A Nano medicine 'Niuhuang Ninggong' and its preparing process |
| 09/11/2002 | CN1368085A Nano medicine 'Niuhuang Xiling' and its preparing process |
| 09/11/2002 | CN1368083A Nano medicine 'Pianzaihuang' and its preparing process |
| 09/11/2002 | CN1368080A Nano medicine for building-up body and its preparing process |
| 09/11/2002 | CN1368079A Nano medicine 'Qingyangshen' and its preparing process |
| 09/11/2002 | CN1368076A Nano cohole tortoise medicine and its preparing process |
| 09/11/2002 | CN1368075A Nano medicine 'Relinqing' and its preparing process |
| 09/11/2002 | CN1368072A Nano medicine 'Zuanshanfeng' and its preparing process |
| 09/11/2002 | CN1368062A Nano medicine 'Zaorenanshen' and its preparing process |
| 09/11/2002 | CN1368054A Process for preparing soft body of pearl shell as Chinese-medicinal material |
| 09/11/2002 | CN1090634C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 09/11/2002 | CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same |
| 09/11/2002 | CN1090627C 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090620C New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
| 09/11/2002 | CN1090504C Chinese medicine preparation for curing hyperplasia of mamary glands and its preparation method |
| 09/11/2002 | CN1090491C Oxygen-making up and stamina-strenthening liquid |
| 09/11/2002 | CN1090489C Anti-fatigue farmaceutical and its prepn. process |
| 09/11/2002 | CN1090482C Massage oil for human skin |
| 09/11/2002 | CN1090480C Phenoxy piperazine derivatives for treating disorders of dopamine system |
| 09/11/2002 | CN1090479C Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor |
| 09/10/2002 | US6448468 Transgenetic mouse which comprises an inactive Peg3 gene, and the use thereof |
| 09/10/2002 | US6448429 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 09/10/2002 | US6448397 Treating central nervous system diseases with modulation of 5-ht activity; adrenergic, dopaminergic, and serotonergic neurotransmitters; psychosis, paraphrenia, depression, mania, schizophrenia, anxiety, migraine headache, drug addiction |
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448288 Cannabinoid drugs |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448285 Disorders associated with overactivity of 5 alpha reductase; androgen dependent disorders such as seborrhoea, acne, hirsutism and/or androgenic alopecia |
| 09/10/2002 | US6448284 Substituted tricyclics |
| 09/10/2002 | US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448272 Myt1 kinase inhibitors |
| 09/10/2002 | US6448271 Substituted benzimidazoles and their use as parp inhibitors |
| 09/10/2002 | US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
| 09/10/2002 | US6448268 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448259 Cycloalkyl-4-oxonicotinic carboxamides; agonists, antagonists or inverse agonists for gamma aminobutyric acid binding site, the benzodiazepine receptor; anxiety, sleep and seizure disorders sedative, anxiolytic and anticonvulsant activity |
| 09/10/2002 | US6448258 Heterocyclic amine compounds |
| 09/10/2002 | US6448256 Precursors of n-substituted derivatives of 6-aminouracils, 6-aminoisocytosines, guanines and 2-aminoadenines having a cleavable ester group; greater water solubility and oral bioavailability; treating gram positive bacterial infections |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | US6448239 Porphyrin ring metallic complexes that are effective peroxynitrite decomposition catalysts for treatment of diseases involving the accumulation of this oxidant, such as altzeimer's disease |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/10/2002 | US6448223 Antagonists of HMG1 for treating inflammatory conditions |
| 09/10/2002 | US6448222 Antitumor agent; antimetastasis agent |
| 09/10/2002 | US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation |
| 09/10/2002 | US6448083 Contacting a mammalian cell with filamentous phage particles presenting a ligand on their surfaces, wherein a vector within the phage encodes a gene product under control of a promoter |
| 09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448037 PgsA |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448021 Cc-chemokine receptor 2 (ccr2) bound by an antibody or functional fragment to block binding of a ligand |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447782 Lipid extract of the Skeletonema algae |
| 09/10/2002 | US6447768 Methods of gene therapy with a DNA sequence encoding NOS |
| 09/10/2002 | CA2288375C Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 09/10/2002 | CA2239159C Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides |
| 09/10/2002 | CA2198562C Method of treating conditions with estrogen agonists |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/10/2002 | CA2192208C Substituted pyrazoles |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068456A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 09/06/2002 | WO2002068440A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/06/2002 | WO2002068439A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/06/2002 | WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases |
| 09/06/2002 | WO2002068423A1 Novel substituted imidazotriazinones |
| 09/06/2002 | WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 09/06/2002 | WO2002068419A1 Pyridopyrimidine or naphthyridine derivative |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068414A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 09/06/2002 | WO2002068411A1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics |
| 09/06/2002 | WO2002068407A1 Benzimidazole compound |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068404A1 Method for producing optically active dihydropyrones |
| 09/06/2002 | WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | WO2002068390A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068387A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002068342A1 Method and device for manufacturing advanced water containing ultra-fine gold particles |